Prostate cancer — all decisions

The Board granted an effective date of August 10, 2022, for the award of service connection for prostate cancer and related conditions.

The Board denied service connection for prostate cancer, erectile dysfunction, tinnitus, bilateral hearing loss, and an acquired psychiatric disorder. The back condition and frostbite of the hands and feet were remanded for further examination.

The Board granted earlier effective dates for thyroid and prostate cancer service connection, denied increased ratings for psychiatric disorder and tinnitus, granted an increased rating for prostate cancer residuals, and granted service connection for erectile dysfunction.

The Board denied service connection for all claimed conditions as the evidence of record does not support a finding that any diagnosed condition is related to the Veteran's active duty service or to a service-connected disability.

The Board remands the matter for further development, including an explanation of the discrepancy in the examination reports and a rectal examination if medically relevant.

The Board denied service connection for prostate cancer as it is not etiologically linked to the Veteran's active-duty service.

The Board granted service connection for prostate cancer based on new and relevant evidence that was not previously considered.

The Board remands the Veteran's claim for service connection for prostate cancer to verify whether he was exposed to herbicide agents during his service in Japan, as he contends this exposure led to his condition.

The Board remands the claims for service connection for re-admission of prostate cancer with leakage due to surgery and scars due to surgery as secondary to re-admission of prostate cancer for an addendum opinion.

The Board remands the claims for service connection for a back condition, chronic sinusitis, hypertension, residuals of prostate cancer, and erectile dysfunction due to inadequate VA medical opinions.

The Board remands the claim for a pre-decisional duty to assist error, necessitating an examination to assess the nature and etiology of prostate cancer.

The appeal concerning the issues of entitlement to service connection for prostate cancer, chronic sinusitis, and allergic rhinitis is dismissed due to the Veteran's death.

The Board granted an effective date of August 10, 2019, for service connection and special monthly compensation based on loss of use or creative organ (LOCO) but denied higher ratings for prostate cancer residuals and erectile dysfunction.

The Board denied the veteran's claim for a rating greater than 40 percent for residuals of prostate cancer from May 1, 2019.

The Veteran's appeal regarding the claims for service connection for prostate cancer and related hip conditions was dismissed by his attorney.

The Veteran's use of a mesalamine suppository, which is related to his service-connected prostate cancer residuals, caused irreparable damage to his pants in 2023, and he was granted an annual clothing allowance for that year.

The Board remands the matters for further development to ensure compliance with VA's duty to assist, specifically requesting private medical records from Dr. B.P. and Dr. A.

The Veteran's service-connected PTSD alone is found to prevent him from obtaining and maintaining substantially gainful employment, and he is granted a total disability rating based on individual unemployability (TDIU) and special monthly compensation (SMC) based on the statutory housebound criteria.

The Board granted an effective date of August 10, 2022, for the grant of service connection for erectile dysfunction and bowel dysfunction, and a disability rating of 30 percent for bowel dysfunction on and after that date.

The Board remands the claims for service connection for prostate cancer and erectile dysfunction, including as secondary to exposure to toxic chemicals and burn pits, or alternatively, secondary to a service-connected surgical scar status post prostatectomy associated with prostate cancer.